FDA Watch: DOGE Changes at FDA Upend Approval Processes, Observers Say
Pre-submission and Q-Submission meetings apparently have been halted, for now
Pre-submission and Q-Submission meetings apparently have been halted, for now
The US Food and Drug Administration recently issued a letter warning people not to use two different tests produced by Empowered Diagnostics.
The cost of recoveries hit an eight-year high in FY 2021, with the health care industry footing 90 percent of the bill.